H. Naman

562 total citations
12 papers, 164 citations indexed

About

H. Naman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, H. Naman has authored 12 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in H. Naman's work include Advanced Breast Cancer Therapies (2 papers), Breast Cancer Treatment Studies (2 papers) and BRCA gene mutations in cancer (2 papers). H. Naman is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Breast Cancer Treatment Studies (2 papers) and BRCA gene mutations in cancer (2 papers). H. Naman collaborates with scholars based in France, Belgium and Monaco. H. Naman's co-authors include J. Doyen, Scott K. Parks, Paul Hofman, Emmanuel Chamorey, Jean‐Michel Hannoun‐Lévi, Catherine Alix‐Panabières, William Jacot, Jean-Louis Misset, Dominique Spaëth and Joseph Gligorov and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

H. Naman

12 papers receiving 162 citations

Peers

H. Naman

ONCOL

PRM

PFM

Howard West United States

Carol Farhangfar United States

Louisa R. Hoes Netherlands

Scott T.C. Shepherd United Kingdom

Jack Junjie Chan Singapore

Naiba Nabieva Germany

Christian Cailliot France

Denisse Bretel Peru

Jane Banerji United Kingdom

Ryan Massa United States

Howard West United States

H. Naman

111 ×1.1

ONCOL

88 ×1.2

77 ×1.6

PRM

57 ×1.8

18 ×0.8

PFM

Citations per year, relative to H. Naman H. Naman (= 1×) peers Howard West

Countries citing papers authored by H. Naman

Since Specialization

Citations

This map shows the geographic impact of H. Naman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Naman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Naman more than expected).

Fields of papers citing papers by H. Naman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Naman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Naman. The network helps show where H. Naman may publish in the future.

Co-authorship network of co-authors of H. Naman

This figure shows the co-authorship network connecting the top 25 collaborators of H. Naman. A scholar is included among the top collaborators of H. Naman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Naman. H. Naman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bidard, François‐Clément, Étienne Brain, William Jacot, et al.. (2016). First line hormone therapy vs chemotherapy for HR+ HER2- metastatic breast cancer in the phase III STIC CTC trial: clinical choice and validity of CTC count. Annals of Oncology. 27. vi69–vi69. 1 indexed citations

Ganem, G., Éric-Charles Antoine, Chantal Touboul, et al.. (2016). Maintaining professional activity during breast cancer treatment. European Journal of Cancer Care. 25(3). 458–465. 7 indexed citations

Martin, Nicolas, Delphine Borchiellini, Diane Coso, et al.. (2015). High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma. Leukemia & lymphoma. 56(8). 2379–2387. 14 indexed citations

Gligorov, Joseph, Xavier Pivot, William Jacot, et al.. (2015). Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study. The Oncologist. 20(8). 873–879. 35 indexed citations

Mitry, Emmanuel, Catherine Lombard‐Bohas, François‐Xavier Caroli‐Bosc, et al.. (2014). Renal effects of streptozocin: Preliminary results of the STREPTOTOX prospective study.. Journal of Clinical Oncology. 32(15_suppl). e15155–e15155. 2 indexed citations

Ganem, G., H. Naman, Nadine Dohollou, et al.. (2013). Continuing to work while receiving cancer treatment: A financial or a symbolic issue?. Journal of Clinical Oncology. 31(15_suppl). 6603–6603. 1 indexed citations

Gligorov, Joseph, Xavier Pivot, H. Naman, et al.. (2012). Prospective study of the impact of using the 21-gene recurrence score assay on clinical decision making in women with estrogen receptor-positive, HER2-negative, early-stage breast cancer in France.. Journal of Clinical Oncology. 30(15_suppl). 568–568. 12 indexed citations

Doyen, J., Catherine Alix‐Panabières, Paul Hofman, et al.. (2011). Circulating tumor cells in prostate cancer: A potential surrogate marker of survival. Critical Reviews in Oncology/Hematology. 81(3). 241–256. 57 indexed citations

Delord, J.P., Jaafar Bennouna, Pascal Artru, et al.. (2007). Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer. British Journal of Cancer. 97(3). 297–301. 13 indexed citations

10.

Khayat, D., Jean-Pierre Bizzari, M. Frénay, et al.. (1988). Interim Report of Phase II Study of New Nitrosourea S 10036 in Disseminated Malignant Melanoma. JNCI Journal of the National Cancer Institute. 80(17). 1407–1408. 20 indexed citations

11.

Naman, H., et al.. (1983). [Apparently primary malignant secreting renal lymphoma (immunocytoma)].. PubMed. 89(9). 649–53. 1 indexed citations

12.

Naman, H., et al.. (1983). [Breast cancer induced by estrogens in a prostate cancer patient].. PubMed. 89(5). 355–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact